方法：112例2型糖尿病性肾病患者随机分为①对照组：仅用包括降糖疗法的一般糖尿病性肾病治疗方法；
Methods: 112 cases of type 2 diabetic nephropathy were divided into two groups, involved in a randomized control clinical trial.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
结论ICAM - 1 K469E多态性与2型糖尿病伴发肾病的发生有关，K等位基因可能是DN的易感基因。
Conclusions K469E polymorphism of ICAM-1 is associated with type 2 DN, and K allele may be susceptible to DN.
应用推荐